Dogwood Therapeutics Inc (DWTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,008 | 19,186 | 21,835 | 24,586 | 29,795 |
| TOTAL | $15,777 | $20,107 | $23,765 | $28,275 | $31,473 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $15,777 | $20,107 | $23,765 | $28,275 | $31,473 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 354 | 484 | 263 | 615 | 369 |
| Accrued Expenses | 922 | 743 | 644 | 553 | 1,163 |
| TOTAL | $1,276 | $1,227 | $906 | $1,167 | $1,532 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,276 | $1,227 | $906 | $1,167 | $1,532 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 333 | 333 | 333 | 333 | N/A |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -43,925 | -39,414 | -35,304 | -31,021 | -27,965 |
| TOTAL | $14,501 | $18,881 | $22,859 | $27,107 | $29,941 |
| Total Liabilities And Equity | $15,777 | $20,107 | $23,765 | $28,275 | $31,473 |